Advisornet Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.07M | Sell |
2,556
-167
| -6% | -$171K | 0.14% | 137 |
|
|
2026
Q1 | $2.5M | Buy |
2,723
+312
| +13% | +$316K | 0.13% | 147 |
|
|
2025
Q4 | $2.59M | Buy |
2,411
+99
| +4% | +$94.7K | 0.14% | 138 |
|
|
2025
Q3 | $1.76M | Sell |
2,312
-113
| -5% | -$84.1K | 0.1% | 178 |
|
|
2025
Q2 | $1.89M | Sell |
2,425
-11
| -0.5% | -$8.55K | 0.12% | 166 |
|
|
2025
Q1 | $2.01M | Buy |
2,436
+79
| +3% | +$65.7K | 0.15% | 157 |
|
|
2024
Q4 | $1.82M | Sell |
2,357
-841
| -26% | -$696K | 0.15% | 146 |
|
|
2024
Q3 | $2.83M | Buy |
3,198
+226
| +8% | +$203K | 0.21% | 109 |
|
|
2024
Q2 | $2.69M | Sell |
2,972
-36
| -1% | -$28.8K | 0.24% | 100 |
|
|
2024
Q1 | $2.34M | Sell |
3,008
-72
| -2% | -$51.2K | 0.23% | 108 |
|
|
2023
Q4 | $1.8M | Buy |
3,080
+133
| +5% | +$77.6K | 0.17% | 141 |
|
|
2023
Q3 | $1.58M | Sell |
2,947
-799
| -21% | -$412K | 0.14% | 152 |
|
|
2023
Q2 | $1.76M | Sell |
3,746
-118
| -3% | -$49.5K | 0.15% | 150 |
|
|
2023
Q1 | $1.33M | Sell |
3,864
-123
| -3% | -$41.5K | 0.12% | 177 |
|
|
2022
Q4 | $1.46M | Buy |
3,987
+73
| +2% | +$25.9K | 0.14% | 157 |
|
|
2022
Q3 | $1.26M | Sell |
3,914
-2
| -0.1% | -$634 | 0.13% | 176 |
|
|
2022
Q2 | $1.27M | Buy |
3,916
+151
| +4% | +$45.3K | 0.12% | 180 |
|
|
2022
Q1 | $1.08M | Buy |
3,765
+854
| +29% | +$220K | 0.07% | 236 |
|
|
2021
Q4 | $804K | Buy |
2,911
+163
| +6% | +$41.3K | 0.05% | 310 |
|
|
2021
Q3 | $635K | Buy |
2,748
+107
| +4% | +$26.4K | 0.04% | 318 |
|
|
2021
Q2 | $606K | Hold |
2,641
| – | – | 0.04% | 352 |
|
|
2021
Q1 | $493K | Buy |
2,641
+1
| +0% | +$196 | 0.04% | 368 |
|
|
2020
Q4 | $446K | Sell |
2,640
-105
| -4% | -$15.7K | 0.04% | 365 |
|
|
2020
Q3 | $406K | Buy |
2,745
+10
| +0.4% | +$1.55K | 0.03% | 372 |
|
|
2020
Q2 | $449K | Sell |
2,735
-200
| -7% | -$30.7K | 0.04% | 359 |
|
|
2020
Q1 | $407K | Sell |
2,935
-35
| -1% | -$4.81K | 0.04% | 349 |
|
|
2019
Q4 | $390K | Sell |
2,970
-1,675
| -36% | -$194K | 0.03% | 375 |
|
|
2019
Q3 | $519K | Buy |
4,645
+1,761
| +61% | +$196K | 0.05% | 324 |
|
|
2019
Q2 | $320K | Buy |
2,884
+1,239
| +75% | +$146K | 0.04% | 383 |
|
|
2019
Q1 | $213K | Sell |
1,645
-231
| -12% | -$28.1K | 0.03% | 420 |
|
|
2018
Q4 | $217K | Sell |
1,876
-240
| -11% | -$26.8K | 0.03% | 389 |
|
|
2018
Q3 | $227K | Buy |
2,116
+14
| +0.7% | +$1.4K | 0.03% | 394 |
|
|
2018
Q2 | $179K | Sell |
2,102
-432
| -17% | -$35.5K | 0.02% | 420 |
|
|
2018
Q1 | $196K | Sell |
2,534
-14,971
| -86% | -$1.21M | 0.03% | 395 |
|
|
2017
Q4 | $1.48M | Buy |
+17,505
| New | +$1.49M | 0.22% | 93 |
|
Other funds holding LLY
SC
ONB
GIM
Advisornet Financial's LLY Position: Q2 2026 in Review
Advisornet Financial reduced its Eli Lilly (LLY) stake by 6.1% in Q2 2026, selling an estimated $171K and leaving 2,556 shares worth $3.07M. The position accounts for 0.14% of the portfolio, ranked #137.
Advisornet Financial first reported a position in LLY in Q4 2017 and has held it in 35 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Advisornet Financial held 2,556 shares of Eli Lilly worth $3.07M as of Q2 2026.
- Advisornet Financial sold 167 Eli Lilly shares in Q2 2026, an estimated $171K.
- Eli Lilly made up 0.14% of Advisornet Financial's portfolio in Q2 2026, its #137 holding.
- Advisornet Financial first reported a position in Eli Lilly in Q4 2017 and has held it in 35 quarters since.
- 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.